Dr. Wais Afzal, MD

Dr. Afzal practices at Sanford Medical Center - Unit in Sioux Falls, South Dakota.

Dr. Afzal's NPI, 1710377544, was assigned on February 2, 2015. Dr. Afzal holds South Dakota license 11335.

Dr. Afzal's primary practice is Sanford Medical Center - Unit, at 1305 W 18th Street, Sioux Falls, SD 57117 in Minnehaha County. The practice phone is (605) 328-6758.

Dr. Afzal's primary practice is Sanford Medical Center - Unit in Sioux Falls, South Dakota. Dr. Afzal is also affiliated with Sanford USD Medical Center. The medical group on file is Edith Sanford Breast Center Sioux Falls. Dmand AI also links Dr. Afzal to 4 more hospitals, 2 medical groups, 1 dialysis center, 1 group practice or clinic and 1 imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Afzal practices, 9 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Afzal's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Afzal is licensed in South Dakota.

CMS data shows 1,177 Medicare services from Dr. Afzal across 7 procedure codes in 2024, for 382 Medicare patients. Medicare paid $49,782 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 382 Medicare patients who saw Dr. Afzal in 2024. The largest group is 65 to 74, with 193 patients. 75% of them have arthritis, and 72% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Afzal's median patient age at 73, with 62% women.

In 2024, Dr. Afzal wrote 3,674 Medicare Part D claims for 567 patients. 81% of them were for generic drugs. CMS names the drug for 3,503 of them, across 37 drugs with 11 or more claims each, at $2,241,922 in total drug cost. In 2023, CMS named 2,996 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Afzal for performance year 2024, reported as part of a group. Dr. Afzal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Afzal as offering telehealth.

Dmand AI links 6 papers to Dr. Afzal, published from 2011 to 2020. 2016 was the busiest year, with 2. Dr. Afzal's most frequent co-authors are Sarfaraz Hasni, MD, Kam A. Newman, MD and Farshad Bagheri, MD.

CMS Open Payments shows 11 general payments to Dr. Afzal from 6 drug and device companies from 2022 to 2024. Food and beverage make up the largest share, 94% of the total. Abbvie Inc. paid the most, $331.